Matches in Wikidata for { <http://www.wikidata.org/entity/Q62822517> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q62822517 description "clinical trial" @default.
- Q62822517 description "ensayu clínicu" @default.
- Q62822517 description "klinisch onderzoek" @default.
- Q62822517 description "клінічне випробування" @default.
- Q62822517 description "临床试验" @default.
- Q62822517 name "First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin" @default.
- Q62822517 type Item @default.
- Q62822517 label "First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin" @default.
- Q62822517 prefLabel "First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin" @default.
- Q62822517 P1050 Q62822517-38ADBC77-28C9-4431-AD6D-B9C33FEED31C @default.
- Q62822517 P1050 Q62822517-393ACF65-817A-41F7-9CB4-D164C9702464 @default.
- Q62822517 P1132 Q62822517-450587E6-A428-4625-8DA8-BFA16691DB9F @default.
- Q62822517 P1476 Q62822517-F59F693F-51CE-4246-96E4-DE556339D476 @default.
- Q62822517 P17 Q62822517-19082560-F674-4858-82C5-947A625552C5 @default.
- Q62822517 P17 Q62822517-69371CDC-054E-4316-A86E-5F08A23375AB @default.
- Q62822517 P17 Q62822517-88A575D2-E4DD-4E96-BF76-3E040FE59E95 @default.
- Q62822517 P17 Q62822517-E3FBDB13-1720-4298-91D3-3A430731AA03 @default.
- Q62822517 P17 Q62822517-EE8AB8FC-6EB7-4710-826E-5C3A556906B6 @default.
- Q62822517 P2899 Q62822517-9CC154E8-5CED-437D-B517-1B9F905C54AD @default.
- Q62822517 P3098 Q62822517-A3A0CC66-4479-41B7-AD68-C8966CB06A53 @default.
- Q62822517 P31 Q62822517-68B3B892-BF5D-424F-AF7A-A5869097B90D @default.
- Q62822517 P4844 Q62822517-EDD87EB3-6E66-42F5-AA07-FCEC7E7ECBF1 @default.
- Q62822517 P580 Q62822517-635E1A6A-FAA8-4A8F-81A2-B8E1093EDE35 @default.
- Q62822517 P582 Q62822517-06EC63BD-012C-4339-8470-98DB83F53356 @default.
- Q62822517 P6099 Q62822517-27E89D51-E692-4D97-8182-31930BF1A778 @default.
- Q62822517 P6153 Q62822517-2750F7A5-8320-41E9-833A-7A8ED47A407E @default.
- Q62822517 P6153 Q62822517-FDF3FD30-5643-4922-BC91-03D447E05434 @default.
- Q62822517 P8005 Q62822517-409543A3-B5A1-4EBF-92B2-4B094108100E @default.
- Q62822517 P8005 Q62822517-8EF0AE05-BD66-4E7A-9B93-CBCF28C2B356 @default.
- Q62822517 P8363 Q62822517-C86EDEE4-D216-4217-A8B9-31E3D1776B94 @default.
- Q62822517 P859 Q62822517-5ABC5A91-F019-412E-982B-E86F14EA402B @default.
- Q62822517 P1050 Q1077603 @default.
- Q62822517 P1050 Q356033 @default.
- Q62822517 P1132 "+228" @default.
- Q62822517 P1476 "An Open-label, First-in-human, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate, BAY2287411 Injection, in Patients With Solid Tumors Known to Express Mesothelin" @default.
- Q62822517 P17 Q145 @default.
- Q62822517 P17 Q30 @default.
- Q62822517 P17 Q33 @default.
- Q62822517 P17 Q34 @default.
- Q62822517 P17 Q55 @default.
- Q62822517 P2899 "+18" @default.
- Q62822517 P3098 "NCT03507452" @default.
- Q62822517 P31 Q30612 @default.
- Q62822517 P4844 Q11872304 @default.
- Q62822517 P580 "2018-06-13T00:00:00Z" @default.
- Q62822517 P582 "2022-06-06T00:00:00Z" @default.
- Q62822517 P6099 Q5452194 @default.
- Q62822517 P6153 Q1525831 @default.
- Q62822517 P6153 Q633529 @default.
- Q62822517 P8005 Q76649708 @default.
- Q62822517 P8363 Q78089383 @default.
- Q62822517 P859 Q152051 @default.